Biotech Daily Market Report Monday January 8, 2007
January 8th 2007 01:23
SPECIAL SUMMER EDITION
* BIOTECHS BEAT ALL ORDS IN DECEMBER
* PFIZER LICENCE PUSHES BENITEC 428%
BIOTECH DAILY’S TOP 40
The biotechnology sector closed 2006 better than the All Ordinaries, with 25 of the Biotech Daily Top 40 rising in market capitalization, 14 falling and one unchanged.
The Biotech Daily Top 40 Index climbed 9.4 percent in December to $4,756 million compared to the All Ordinaries up 4.2 percent.
The biggest winner was Polartechnics, climbing 164 percent to $29 million; followed by Progen up 62 percent to $263 million; Avexa up 57 percent to $74 million; and Phylogica up 54 percent to $40 million. Other strong gains were Evogenix (45% to $100m); Clinuvel (37% to $202m); Ventracor (34% to $286m); Portland Orthopaedics (29% to $62m); and Peptech (23% to $264m).
To view these articles readers need to subscribe to Biotech Daily.
See details at www.biotechdaily.com.au
| 48 |
| Vote |
Add To: 
subscribe to this blog